Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension

Published:2019-10-01 Issue:10 Volume:179 Page:1433
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Ruzicka Marcel¹²³,Leenen Frans H. H.⁴,Ramsay Tim²,Bugeja Ann¹³,Edwards Cedric¹³,McCormick Brendan¹³,Hiremath Swapnil¹²³

Affiliation:

1. Renal Hypertension Center, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada

2. Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

3. Kidney Research Center, University of Ottawa, Ottawa, Ontario, Canada

4. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2735985/jamainternal_ruzicka_2019_ld_190022.pdf

Reference6 articles.

1. Measuring, analyzing, and managing drug adherence in resistant hypertension.;Burnier;Hypertension,2013

2. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.;Fadl Elmula;Hypertension,2014

3. Can drugs work in patients who do not take them? the problem of non-adherence in resistant hypertension.;Ruzicka;Curr Hypertens Rep,2015

4. Adherence to blood pressure-lowering drugs and resistant hypertension: should trial of direct observation therapy be part of preassessment for renal denervation?;Ruzicka;Can J Cardiol,2013

5. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension.;Brinker;J Am Coll Cardiol,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic options for the treatment of hypertension in pregnancy;Expert Opinion on Pharmacotherapy;2024-09-09

2. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

3. Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran;Journal of the American Heart Association;2024-03-19

4. RNA Interference as a Therapeutic Approach for Managing Hypertension;Clinical Journal of the American Society of Nephrology;2024-02-13

5. Design and Implementation of an Electronic Health Record‐Integrated Hypertension Management Application;Journal of the American Heart Association;2024-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3